Kenvue's Dividend Announcement#
Kenvue Inc. (NYSE:KVUE) has declared a quarterly dividend of $0.2075 per share on its common stock. This announcement was made by the company's Board of Directors and highlights the company's commitment to returning value to its shareholders. The dividend yield, which is the annual dividend payment divided by the stock price, stands at 4.73%. Kenvue has a track record of increasing its dividend for three consecutive years.
Dividend Payment Details#
The declared dividend is set to be paid on May 27, 2026, to shareholders who are on record as of the close of business on May 13, 2026. This means that investors must own shares before this date to receive the upcoming dividend payment.
Company Overview and Recent Performance#
Kenvue is a consumer health company known for popular brands such as Aveeno, Band-Aid, Johnson’s, Listerine, Neutrogena, and Tylenol. Recently, Kenvue reported a 3.2% increase in sales year-over-year for its fourth quarter and fiscal year 2025, surpassing the expected growth of 0.4%. Organic sales, which exclude the effects of acquisitions and divestitures, rose by 1.2% during the same period.
Analyst Insights#
Following this strong performance, several analysts have adjusted their price targets for Kenvue shares. UBS increased its target from $17 to $19, citing improved profit margins and a favorable tax rate. Canaccord Genuity also raised its target from $17 to $18 while maintaining a Hold rating. Barclays has set its price target at $19, noting Kenvue's successful expansion in underrepresented areas of its consumer health segments. Additionally, Kenvue appointed Heather Howlett as interim Chief Financial Officer effective May 12, 2026, following the departure of Amit Banati. These developments provide valuable insights into Kenvue's ongoing financial health and strategic direction.